Anna Djos

University of Gothenburg — Sweden

Medicine · Health Sciences

15h-index932citations67works0.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroblastoma Research and Treatments(63), Cancer, Hypoxia, and Metabolism(18), Neuroendocrine Tumor Research Advances(16), Lung Cancer Research Studies(14), Cancer therapeutics and mechanisms(12)

Publications67 total

DNA methylation profiling for molecular classification of neuroblastoma
Clinical Epigenetics·2025· 3 citedOpen Access
Gain of chromosome 17 is an early genetic abnormality in neuroblastoma with PPM1D emerging as a strong candidate oncogene driving tumor progression
Cancer Letters·2025Open Access
Comparative analysis of whole-genome sequencing of tumor and cfDNA in a neuroblastoma patient: a case report
Frontiers in Oncology·2025Open Access
Figure S4 from Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis
2025Open Access
Supplementary data 3 from Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis
2025Open Access
Figure S2 from Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis
2025Open Access
Figure S3 from Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis
2025Open Access
Supplementary information from Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis
2025Open Access
Figure S1 from Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis
2025Open Access
Supplementary data 1 from Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis
2025Open Access
Supplementary data 2 from Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis
2025Open Access
Gain of chromosome 17 is an early genetic abnormality in neuroblastoma with PPM1D emerging as a strong candidate oncogene driving tumor progression
2025Open Access
Gain of Chromosome 17 is an Early Genetic Abnormality in Neuroblastoma with Ppm1d Emerging as a Strong Candidate Oncogene Driving Tumor Progression
SSRN Electronic Journal·2025Open Access
METTL3/MYCN cooperation drives neural crest differentiation and provides therapeutic vulnerability in neuroblastoma
The EMBO Journal·2024· 3 citedOpen Access
Figure S3 from Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis
2024Open Access
Supplementary data 3 from Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis
2024Open Access
Figure S4 from Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis
2024Open Access
Figure 5 from Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis
2024Open Access
Figure S2 from Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis
2024Open Access
Figure 1 from Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis
2024Open Access
page 1 of 4Next →

Frequent Co-authors

Tommy Martinsson(48), Per Kogner(43), Susanne Fransson(41), Ruth H. Palmer(24), Bengt Hallberg(24), Jennie Gaarder(22), Kleopatra Georgantzi(21), Catarina Träger(19), Torben Ek(19), Diana Treis(18), Hartmut Vogt(18), Henrik Fagman(18), Raghda R. Ibrahim(17), Ida Rahmqvist(17), Elisabeth Mellström(17), Fani Pujol-Calderón(17), Christoffer Vannas(17), Lina Hansson(17), Tobias Österlund(17), Tzu‐Po Chuang(17)